# Prospective Study of Multi-centers Exploring the Difference of Clinical Impact by Using Respiratory Pathogen ID/AMR Panel (RPIP) Versus Untarget Metagenomic Next-generation Sequencing (mNGS) and Multiplex PCR in Pathogen Identification of Pneumonia Patients in Intensive Care Unit

> **NCT07626073** · — · ENROLLING_BY_INVITATION · sponsor: **China Medical University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Respiratory Pathogens

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07626073
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-20
- **Primary completion:** 2028-04-09
- **Final completion:** 2028-04-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07626073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07626073, "Prospective Study of Multi-centers Exploring the Difference of Clinical Impact by Using Respiratory Pathogen ID/AMR Panel (RPIP) Versus Untarget Metagenomic Next-generation Sequencing (mNGS) and Multiplex PCR in Pathogen Identification of Pneumonia Patients in Intensive Care Unit". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07626073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*